These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Radionuclide Imaging in Congestive Heart Failure: Assessment of Viability, Sarcoidosis, and Amyloidosis. Bois JP; Chareonthaitawee P Cardiol Clin; 2016 Feb; 34(1):119-32. PubMed ID: 26590784 [TBL] [Abstract][Full Text] [Related]
23. Endomyocardial biopsy in 30 patients with primary amyloidosis and suspected cardiac involvement. Pellikka PA; Holmes DR; Edwards WD; Nishimura RA; Tajik AJ; Kyle RA Arch Intern Med; 1988 Mar; 148(3):662-6. PubMed ID: 3341867 [TBL] [Abstract][Full Text] [Related]
24. Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis. Gertz MA; Brown ML; Hauser MF; Kyle RA Arch Intern Med; 1987 Jun; 147(6):1039-44. PubMed ID: 3036031 [TBL] [Abstract][Full Text] [Related]
25. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. Vogelsberg H; Mahrholdt H; Deluigi CC; Yilmaz A; Kispert EM; Greulich S; Klingel K; Kandolf R; Sechtem U J Am Coll Cardiol; 2008 Mar; 51(10):1022-30. PubMed ID: 18325442 [TBL] [Abstract][Full Text] [Related]
26. Multimodality imaging for the diagnosis of infiltrative cardiomyopathies. Vidula MK; Bravo PE Heart; 2022 Jan; 108(2):98-104. PubMed ID: 34039679 [TBL] [Abstract][Full Text] [Related]
27. Myocardial technetium-99m-pyrophosphate scintigraphy and echocardiography in the diagnosis of cardiac amyloidosis. Planinc D; Franceschi D; Zigman M; Jerić M; Pagon LJ; Mihatov S; Rudar M Acta Cardiol; 1992; 47(4):391-401. PubMed ID: 1387996 [No Abstract] [Full Text] [Related]
28. Value of classical criteria for diagnosis of cardiac amyloidosis re-evaluated with magnetic resonance. Pozo E; Sanz J Expert Rev Cardiovasc Ther; 2014 Oct; 12(10):1133-6. PubMed ID: 25205232 [TBL] [Abstract][Full Text] [Related]
29. The role of echocardiography in the non-invasive diagnosis of cardiac amyloidosis. Cacciapuoti F J Echocardiogr; 2015 Sep; 13(3):84-9. PubMed ID: 26184746 [TBL] [Abstract][Full Text] [Related]
30. A special case of hypertrophic cardiomyopathy with a differential diagnosis of isolated cardiac amyloidosis or junctophilin type 2 associated cardiomyopathy. De Bruijn S; Galloo X; De Keulenaer G; Prihadi EA; Brands C; Helbert M Acta Clin Belg; 2021 Apr; 76(2):136-143. PubMed ID: 31478477 [TBL] [Abstract][Full Text] [Related]
31. Noninvasive risk stratification of patients with transthyretin amyloidosis. Kristen AV; Scherer K; Buss S; aus dem Siepen F; Haufe S; Bauer R; Hinderhofer K; Giannitsis E; Hardt S; Haberkorn U; Katus HA; Steen H JACC Cardiovasc Imaging; 2014 May; 7(5):502-10. PubMed ID: 24726252 [TBL] [Abstract][Full Text] [Related]
32. The mosaic of the cardiac amyloidosis diagnosis: role of imaging in subtypes and stages of the disease. Di Bella G; Pizzino F; Minutoli F; Zito C; Donato R; Dattilo G; Oreto G; Baldari S; Vita G; Khandheria BK; Carerj S Eur Heart J Cardiovasc Imaging; 2014 Dec; 15(12):1307-15. PubMed ID: 25190073 [TBL] [Abstract][Full Text] [Related]
33. Nuclear Imaging for the Diagnosis of Cardiac Amyloidosis in 2021. Li W; Uppal D; Wang YC; Xu X; Kokkinidis DG; Travin MI; Tauras JM Diagnostics (Basel); 2021 May; 11(6):. PubMed ID: 34070853 [TBL] [Abstract][Full Text] [Related]
35. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy. Bennani Smires Y; Victor G; Ribes D; Berry M; Cognet T; Méjean S; Huart A; Roussel M; Petermann A; Roncalli J; Carrié D; Rousseau H; Berry I; Chauveau D; Galinier M; Lairez O Int J Cardiovasc Imaging; 2016 Sep; 32(9):1403-1413. PubMed ID: 27240600 [TBL] [Abstract][Full Text] [Related]
36. Challenges and Strategies in the Diagnosis of Cardiac Amyloidosis. Fine NM Can J Cardiol; 2020 Mar; 36(3):441-443. PubMed ID: 31964561 [TBL] [Abstract][Full Text] [Related]